Pediatrix Medical
297 hedge funds and large institutions have $1.78B invested in Pediatrix Medical in 2026 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 106 increasing their positions, 100 reducing their positions, and 36 closing their positions.
11% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 36
3.71% more ownership
Funds ownership: 96.38% → 100.09% (+3.7%)
6% more repeat investments, than reductions
Existing positions increased: 106 | Existing positions reduced: 100
0% more capital invested
Capital invested by funds: $1.77B → $1.78B (+$5.28M)
1% less funds holding
Funds holding: 299 → 297 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$42.7M |
| 2 |
RA
Royce & Associates
New York
|
+$8.83M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$7.08M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$6.99M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
-$17.2M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$12.1M |
| 3 |
JP Morgan Chase
New York
|
-$9.94M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.02M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$5.82M |
MD Hedge Fund Activity: Q1 2026 in Review
297 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q1 2026, worth a combined $1.78B — up 0.3% from $1.77B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new MD positions and 36 closed out — a net gain of 4 holders — while 106 added to existing stakes and 100 trimmed.
The largest buyer was Wasatch Advisors, opening a new position worth an estimated $42.7M. The largest seller was Boston Partners, exiting entirely with an estimated $17.2M sold.
- 297 institutional investors held Pediatrix Medical (MD) as of Q1 2026, down from 299 in Q4 2025.
- Funds reported $1.78B of Pediatrix Medical stock for Q1 2026, up 0.3% quarter-over-quarter.
- 40 funds opened new Pediatrix Medical positions in Q1 2026 and 36 closed out, a net change of +4 holders.
- The largest Pediatrix Medical buyer in Q1 2026 was Wasatch Advisors, an estimated $42.7M added.
- The largest Pediatrix Medical seller in Q1 2026 was Boston Partners, an estimated $17.2M sold.
Based on aggregated 13F filings for Q1 2026.